ECM
Everence Capital Management Portfolio holdings
AUM
$1.55B
1-Year Return
22.02%
This Quarter Return
+14.61%
1 Year Return
+22.02%
3 Year Return
+82.69%
5 Year Return
+144.46%
10 Year Return
+389.74%
AUM
$572M
AUM Growth
+$141M
(+33%)
Cap. Flow
+$84.6M
Cap. Flow
% of AUM
14.78%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
658
New
238
Increased
175
Reduced
106
Closed
39
Top Buys
| 1 |
Linde
LIN
|
$2.49M |
| 2 |
Walt Disney
DIS
|
$1.59M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$1.49M |
| 4 |
Verizon
VZ
|
$1.48M |
| 5 |
Procter & Gamble
PG
|
$1.44M |
Top Sells
| 1 |
Apple
AAPL
|
$3.89M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
$1.35M |
| 3 |
DuPont de Nemours
DD
|
$1.29M |
| 4 |
UnitedHealth
UNH
|
$1.29M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$904K |
Sector Composition
| 1 | Technology | 18.69% |
| 2 | Financials | 15.22% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Communication Services | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Marsh & McLennan
MMC
$100B
| $1.72M | 0.3% |
18,311
+2,995
| +20% | +$281K |
|
77
Intuit
INTU
$188B
| $1.67M | 0.29% |
6,400
+1,236
| +24% | +$323K |
|
78
TransDigm Group
TDG
$71.6B
| $1.67M | 0.29% |
3,667
-1,152
| -24% | -$523K |
|
79
CVS Health
CVS
$93.6B
| $1.65M | 0.29% |
30,581
+3,702
| +14% | +$200K |
|
80
Stryker
SYK
$150B
| $1.65M | 0.29% |
8,335
-5
| -0.1% | -$987 |
|
81
FedEx
FDX
$53.7B
| $1.6M | 0.28% |
8,818
+3,420
| +63% | +$621K |
|
82
Travelers Companies
TRV
$62B
| $1.59M | 0.28% |
11,557
+3,504
| +44% | +$481K |
|
83
Charter Communications
CHTR
$35.7B
| $1.58M | 0.28% |
4,547
-22
| -0.5% | -$7.63K |
|
84
Simon Property Group
SPG
$59.5B
| $1.57M | 0.27% |
8,601
+4,508
| +110% | +$821K |
|
85
American Express
AXP
$227B
| $1.56M | 0.27% |
14,308
-2,479
| -15% | -$271K |
|
86
Qualcomm
QCOM
$172B
| $1.56M | 0.27% |
27,427
-1,907
| -7% | -$109K |
|
87
Zoetis
ZTS
$67.9B
| $1.55M | 0.27% |
15,365
+722
| +5% | +$72.7K |
|
88
Gilead Sciences
GILD
$143B
| $1.54M | 0.27% |
23,730
-6,791
| -22% | -$442K |
|
89
Intuitive Surgical
ISRG
$167B
| $1.52M | 0.27% |
7,983
| – | – |
|
90
Blackrock
BLK
$170B
| $1.51M | 0.26% |
3,532
+459
| +15% | +$196K |
|
91
Elevance Health
ELV
$70.6B
| $1.49M | 0.26% |
5,190
-1,431
| -22% | -$411K |
|
92
CSX Corp
CSX
$60.6B
| $1.46M | 0.25% |
58,419
-3,105
| -5% | -$77.4K |
|
93
Johnson Controls International
JCI
$69.5B
| $1.44M | 0.25% |
38,862
-6,480
| -14% | -$239K |
|
94
Goldman Sachs
GS
$223B
| $1.42M | 0.25% |
7,387
| – | – |
|
95
American International
AIG
$43.9B
| $1.41M | 0.25% |
32,680
-2,037
| -6% | -$87.7K |
|
96
Crown Castle
CCI
$41.9B
| $1.38M | 0.24% |
10,749
-219
| -2% | -$28K |
|
97
Colgate-Palmolive
CL
$68.8B
| $1.37M | 0.24% |
20,017
+3,040
| +18% | +$208K |
|
98
Progressive
PGR
$143B
| $1.36M | 0.24% |
18,823
+1,007
| +6% | +$72.6K |
|
99
Boston Scientific
BSX
$159B
| $1.36M | 0.24% |
35,332
+7,140
| +25% | +$274K |
|
100
TJX Companies
TJX
$155B
| $1.35M | 0.24% |
25,363
+4,577
| +22% | +$244K |
|